"Bezisterim" has been approved as the non-proprietary name for NE3107 Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammationCARSON CITY,
BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday.
The Dow traded up 0.42% to 35,564.02 while the NASDAQ rose 0.17% to 14,305.43. The S&P 500 also rose, gaining, 0.26% to 4,566.65.
Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.